Transmembrane domain of amyloid precursor protein (APP) is cleaved by α-, β-, and ϒ-secretase. Consequently, β-amyloid peptides (1-40), (1-42) and (1-28) have extensively been studied in relation to alzheimer disease.
Bio-Synthesis offers comprehensive array of human and rat beta amyloid peptide fragments for Alzherimer’s disease (AD) and other neurodegenerative disease. For detail listings, click on the link below.
- β-amyloid peptides
- β-amyloid peptide conjugates including oligonucleotide, oligomimetic, metal chelators, dye-labeled